Chison Medical Technologies Co., Ltd. (SHA:688358)

SHA:688358 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	455.88	468.7	480.89	375.69	394.91	329.02
Other Revenue	-	-	2.95	5.16	2.9	4.07
Revenue	455.88	468.7	483.84	380.84	397.81	333.09
Revenue Growth (YoY)	-0.74%	-3.13%	27.05%	-4.26%	19.43%	-9.92%
Cost of Revenue	-5.98	192.38	208.34	160.6	178.89	139.21
Gross Profit	461.86	276.32	275.5	220.24	218.92	193.88
Selling, General & Admin	0.31	92.63	84.26	81.84	76.15	56.91
Research & Development	-2.2	79.63	77.07	77.88	72.29	55.64
Other Operating Expenses	307.98	-7.94	-3.43	-4.3	-2.49	-2.01
Operating Expenses	305.33	164.33	161.48	154.02	146.68	111.67
Operating Income	156.54	111.99	114.02	66.22	72.24	82.21
Interest Expense	-0.32	-	-0.36	-0.11	-0.07	-
Interest & Investment Income	0.12	6.12	29.6	16.43	19.59	27.82
Currency Exchange Gain (Loss)	-	-	5.49	26.13	-6.02	-8.54
Other Non Operating Income (Expenses)	-3.46	38.52	-0.38	-0.38	-0.37	-0.27
EBT Excluding Unusual Items	152.87	156.62	148.36	108.29	85.37	101.22
Gain (Loss) on Sale of Investments	-0.35	0.17	2.93	-1.37	0.43	-
Gain (Loss) on Sale of Assets	0.99	4.61	3.02	-0.5	30.26	0.01
Asset Writedown	-0.47	-4.56	-0.06	-0.51	-1.59	-
Other Unusual Items	-0.12	-	7.94	9.22	10.08	10.28
Pretax Income	152.93	156.85	162.19	115.13	124.54	111.51
Income Tax Expense	13.5	16.34	15.71	9.29	12.07	11.88
Net Income	139.43	140.51	146.48	105.84	112.47	99.64
Net Income to Common	139.43	140.51	146.48	105.84	112.47	99.64
Net Income Growth	-0.05%	-4.08%	38.40%	-5.89%	12.88%	-5.23%
Shares Outstanding (Basic)	112	112	110	113	112	112
Shares Outstanding (Diluted)	112	112	110	113	112	112
Shares Change (YoY)	2.16%	1.25%	-2.19%	0.11%	0.79%	28.88%
EPS (Basic)	1.24	1.26	1.33	0.94	1.00	0.89
EPS (Diluted)	1.24	1.26	1.33	0.94	1.00	0.89
EPS Growth	-2.17%	-5.26%	41.49%	-6.00%	12.00%	-26.47%
Free Cash Flow	-	131.83	51.9	11.53	0.78	51.56
Free Cash Flow Per Share	-	1.18	0.47	0.10	0.01	0.46
Dividend Per Share	-	-	0.800	0.700	0.357	0.571
Dividend Growth	-	-	14.29%	96.02%	-37.50%	-20.01%
Gross Margin	101.31%	58.95%	56.94%	57.83%	55.03%	58.21%
Operating Margin	34.34%	23.89%	23.57%	17.39%	18.16%	24.68%
Profit Margin	30.59%	29.98%	30.28%	27.79%	28.27%	29.91%
Free Cash Flow Margin	-	28.13%	10.73%	3.03%	0.19%	15.48%
EBITDA	-	123.71	125.14	78.3	81.53	90.4
EBITDA Margin	-	26.39%	25.86%	20.56%	20.50%	27.14%
D&A For EBITDA	-	11.72	11.13	12.07	9.29	8.19
EBIT	156.54	111.99	114.02	66.22	72.24	82.21
EBIT Margin	34.34%	23.89%	23.57%	17.39%	18.16%	24.68%
Effective Tax Rate	8.83%	10.42%	9.69%	8.07%	9.69%	10.65%
Revenue as Reported	-	-	483.84	380.84	397.81	333.09
Advertising Expenses	-	-	3.38	2.64	4.1	4.66

Source: S&P Global Market Intelligence. Standard template. Financial Sources.